Atara Biotherapeutics, Inc. · NASDAQ:ATRA
EcoR1 Capital, LLC reported a 17.40% stake in Atara Biotherapeutics, Inc. (Schedule 13G/A)
Event May 7, 2026 · Filed May 7, 2026
EcoR1 Capital, LLC reported a 17.40% stake in Atara Biotherapeutics, Inc., 1,552,000 shares, as a passive investor on May 7, 2026. Filed May 7, 2026 (Schedule 13G/A).
- Stake
- 17.40%
- Shares
- 1,552,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| EcoR1 Capital, LLC | 17.40% | 1,552,000 |
| Oleg Nodelman | 17.40% | 1,552,000 |
| EcoR1 Capital Fund Qualified, L.P. | 16.20% | 1,445,609 |
Source
Related
- Atara Biotherapeutics, Inc.
- EcoR1 Capital, LLC
- Atara Biotherapeutics, Inc. shareholders
- Schedule 13G/A · EcoR1 Capital, LLC · Nov 14, 2025
- Form 4 · Cherry Brian N · Sep 4, 2026
- Form 4 · Nguyen AnhCo · Aug 26, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Form 4 · Redmile Group, LLC · Jul 24, 2026
- Schedule 13D/A · Redmile Group, LLC · Jul 24, 2026